Clinically isolated syndrome: the rationale for early treatment

被引：0
|
作者：
Giancarlo Comi
机构：
[1] Vita-Salute San Raffaele University,G Comi is a Professor of Neurology and Chairman of the Department of Neurology
[2] Milan,undefined
[3] Italy.,undefined
来源：
Nature Clinical Practice Neurology | 2008年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Immunotherapy seems to alter the natural course of multiple sclerosis (MS), so there is a general view that treatment should be initiated as soon as a diagnosis is made. In this Viewpoint, Giancarlo Comi makes a case for extending the early treatment approach to patients with a first neurological event suggestive of MS.
引用
收藏
页码：234 / 235
页数：1
相关论文
共 50 条
  • [1] Clinically isolated syndrome: the rationale for early treatment
    Comi, Giancarlo
    NATURE CLINICAL PRACTICE NEUROLOGY, 2008, 4 (05): : 234 - 235
  • [2] Early Treatment in Clinically Isolated Syndrome to Decrease Relapse Rate
    Jeong, W. K.
    Lee, H. J.
    Kwon, S. W.
    Seok, J. M.
    Min, J. H.
    Kim, B. J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP46 - NP47
  • [3] Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome
    Comi, Giancarlo
    Martinelli, Vittorio
    Rodegher, Mariaemma
    Moiola, Lucia
    Leocani, Letizia
    Bajenaru, Ovidiu
    Carra, Adriana
    Elovaara, Irina
    Fazekas, Franz
    Hartung, Hans-Peter
    Hillert, Jan
    King, John
    Komoly, Samuel
    Lubetzki, Catherine
    Montalban, Xavier
    Myhr, Kjell-Morten
    Preziosa, Paolo
    Ravnborg, Mads
    Rieckmann, Peter
    Rocca, Maria A.
    Wynn, Daniel
    Young, Carolyn
    Filippi, Massimo
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (08) : 1074 - 1083
  • [4] Treatment of clinically isolated syndrome: to be PreClSe
    Miller, David H.
    Leary, Siobhan M.
    LANCET, 2009, 374 (9700): : 1475 - 1476
  • [5] Drug Treatment of Clinically Isolated Syndrome
    Foerster, Moritz
    Graf, Jonas
    Mares, Jan
    Aktas, Orhan
    Hartung, Hans-Peter
    Kremer, David
    CNS DRUGS, 2019, 33 (07) : 659 - 676
  • [6] Drug Treatment of Clinically Isolated Syndrome
    Moritz Förster
    Jonas Graf
    Jan Mares
    Orhan Aktas
    Hans-Peter Hartung
    David Kremer
    CNS Drugs, 2019, 33 : 659 - 676
  • [7] Could the type of presentation of clinically isolated syndrome be an indication to start early treatment?
    Clerico, M.
    Versino, E.
    Contessa, G.
    De Mercanti, S.
    Durelli, L.
    JOURNAL OF NEUROLOGY, 2010, 257 : S73 - S73
  • [8] Early treatment to prevent conversion of clinically isolated syndrome to clinically defined multiple sclerosis: a Cochrane metanalysis
    Clerico, Marinella
    Faggiano, Fabrizio
    Rice, George P.
    Palace, Jacqueline
    Tintore, Mar
    Durelli, Luca
    MULTIPLE SCLEROSIS, 2008, 14 : S61 - S61
  • [9] Early evoked potentials in clinically isolated syndrome patients
    Parra, S.
    Bosca, I.
    Magraner, M. J.
    Simo, M.
    Bosca, M.
    Belloch, V.
    Coret, F.
    Vilela, C.
    Casanova, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 246 - 246
  • [10] Radiologically isolated syndrome and clinically isolated syndrome
    Filippi, Massimo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
12345